Mission
THE ADENOID CYCTIC CARCINOMA RESEARCH FOUNDATION (ACCRF) SUPPORTS RESEARCH INTO ADENOID CYSTIC CARCINOMA THAT WILL ACCELERATE THE DEVELOPMENT OF IMPROVED THERAPIES AND A CURE FOR THE DISEASE.
Public Charity
THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION
THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION is a nonprofit organization categorized as Public Charity based in NEEDHAM, MA. Its most recent IRS filing (2025) reports revenue of $1.2M, expenses of $1.2M, total assets of $2.3M. Imperigo tracks 67 reported grant relationships connected to this organization totaling approximately $3.7M.
EIN: 206745475
NEEDHAM, MA
Fund Raising & Fund Distribution
NTEE: H12
Latest filing: 2025
Total Revenue$1.2M
Total Expenses$1.2M
Total Assets$2.3M
Grant Records67
Funding Total$3.7M
Filing Years2021–2025
Where $100 goes at The Adenoid Cystic Carcinoma Research Foundation
How The Adenoid Cystic Carcinoma Research Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$92
Programs
the work itself
$6
Management
running the organization
$2
Fundraising
raising the next dollar
Inside the $92 for programs
$82
Scientific research
$10
Patient education
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
RARE CANCER RESEARCH
$53,909
$50,000
FOR RECIPIENT'S EXEMPT PURPOSE
$31,000
GENERAL SUPPORT
$30,080
GENERAL SUPPORT
$30,080
Showing up to 5 of 67 total records — full history available with membership.
Officers & Directors
Director
Bozho Todorich
Director
David Morse
Director
Elizabeth Wehlage
Director
Emma Kinloch
Executive Dir.
Jeffrey Kaufman
Director
Marnie Kaufman
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $1.2M | $1.2M | $2.3M |
| 2024 | $1.1M | $1.5M | $2.3M |
| 2023 | $1.9M | $1.9M | $2.7M |
| 2022 | $1.4M | $1.6M | $2.7M |
| 2021 | $2.4M | $2.1M | $3.1M |
Between 2021 and 2025, reported annual revenue declined from $2.4M to $1.2M (-52%), with total assets most recently reported at $2.3M.
Interactive year-over-year charts and full filing details available with membership.